Caricamento...
An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics
PD98059 is a reversible MEK inhibitor that we are investigating as a potential treatment for neurochemical changes in the brain that drive neurohumoral excitation in heart failure. In preliminary studies in a rat model that closely resembles human heart failure, we found that PD98059 gains access to...
Salvato in:
| Pubblicato in: | Drug Deliv Transl Res |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7647946/ https://ncbi.nlm.nih.gov/pubmed/32378175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13346-020-00758-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|